Kan Gao

Chris O’Brien Lifehouse

Papers

1

Total Citations

5

H-Index

1

About

Dr. Kan Gao is a head and neck surgical oncologist whose research focuses on advancing transoral robotic surgery (TORS) and optimizing treatment de-escalation for oropharyngeal cancer. In his most-cited work, a 2022 cohort study, Dr. Gao demonstrated that carefully selected patients undergoing TORS can safely avoid primary site adjuvant radiotherapy, thereby preserving swallowing function and quality of life without compromising disease control. This contribution addresses a critical clinical challenge: reducing the long-term toxicity of combined modality therapy while maintaining oncologic outcomes. Although his citation count is still building, his work has already influenced discussions on personalized, function-sparing approaches in head and neck oncology. Dr. Gao’s research sits at the intersection of surgical innovation and survivorship, offering evidence that robotic surgery may enable more tailored adjuvant treatment decisions. His findings are particularly relevant for patients seeking to minimize radiation-related dysphagia and xerostomia. As a rising voice in the field, Dr. Gao continues to refine protocols that balance cancer cure with quality of life, making him a key researcher to watch in the evolving landscape of minimally invasive head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago